Burning Rock Biotech (BNR) Net Income towards Common Stockholders (2020 - 2025)
Historic Net Income towards Common Stockholders for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.
- Burning Rock Biotech's Net Income towards Common Stockholders rose 5377.82% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.3 million, marking a year-over-year increase of 7442.83%. This contributed to the annual value of -$45.9 million for FY2024, which is 5017.11% up from last year.
- As of Q3 2025, Burning Rock Biotech's Net Income towards Common Stockholders stood at -$2.4 million, which was up 5377.82% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Net Income towards Common Stockholders registered a high of -$1.4 million during Q2 2025, and its lowest value of -$41.2 million during Q1 2022.
- In the last 5 years, Burning Rock Biotech's Net Income towards Common Stockholders had a median value of -$24.0 million in 2023 and averaged -$21.7 million.
- As far as peak fluctuations go, Burning Rock Biotech's Net Income towards Common Stockholders plummeted by 10362.12% in 2021, and later soared by 9089.2% in 2025.
- Burning Rock Biotech's Net Income towards Common Stockholders (Quarter) stood at -$39.4 million in 2021, then rose by 20.45% to -$31.4 million in 2022, then increased by 27.12% to -$22.8 million in 2023, then skyrocketed by 57.63% to -$9.7 million in 2024, then surged by 75.67% to -$2.4 million in 2025.
- Its Net Income towards Common Stockholders was -$2.4 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$1.9 million in Q1 2025.